Synergistic Protection System for Human Papilloma Virus and Sexually Transmitted Infections

Publication ID: 24-11857675_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Protection System for Human Papilloma Virus and Sexually Transmitted Infections,” Published Technical Disclosure No. 24-11857675_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857675_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,675.

Summary of the Inventive Concept

A novel system integrating copper-based uterine cervical devices with AI, IoT, blockchain, and nanomaterial technologies to provide enhanced protection against human papilloma virus and sexually transmitted infections, while optimizing treatment protocols and user health metrics.

Background and Problem Solved

The original patent disclosed a method for reducing the incidence and prevalence of human papilloma virus (HPV) using a copper-based uterine cervical device. However, the method had limitations in terms of tracking user health metrics, predicting disease risk, and providing personalized treatment recommendations. The new inventive concept addresses these limitations by synergistically combining the original method with advanced technologies, enabling a more comprehensive and effective approach to preventing HPV and sexually transmitted infections.

Detailed Description of the Inventive Concept

The synergistic protection system comprises a wearable device with a copper-based uterine cervical module, a blockchain-based data storage module, and an AI-powered analytics module. The copper-based module reduces the incidence and prevalence of HPV, while the blockchain module securely stores user health metrics and treatment protocols. The AI-powered analytics module predicts disease risk and provides personalized treatment recommendations based on user-specific data. Additionally, IoT sensors can be integrated to monitor and adjust the device's performance in real-time, and nanomaterial-based delivery systems can be used for targeted release of therapeutic agents. The system enables real-time monitoring, personalized treatment, and optimized health outcomes.

Novelty and Inventive Step

The new claims introduce the innovative combination of copper-based uterine cervical devices with AI, IoT, blockchain, and nanomaterial technologies, which provides a synergistic effect in preventing HPV and sexually transmitted infections. This integration of distinct technologies is new and non-obvious compared to the original patent, and enables a more comprehensive and effective approach to preventing these diseases.

Alternative Embodiments and Variations

Alternative embodiments of the synergistic protection system could include different wearable device designs, varying AI-powered analytics algorithms, or integration with other health monitoring systems. Variations could also include using different materials or geometries for the uterine cervical module, or incorporating additional sensors or actuators to enhance the system's functionality.

Potential Commercial Applications and Market

The synergistic protection system has significant commercial potential in the healthcare and medical device industries, particularly in the areas of women's health and infectious disease prevention. The system's ability to provide enhanced protection against HPV and sexually transmitted infections, while optimizing treatment protocols and user health metrics, makes it an attractive solution for healthcare providers, insurers, and patients.

CPC Classifications

SectionClassGroup
A A61 A61K9/0039
A A61 A61F6/144
A A61 A61K33/34

Original Patent Information

Patent NumberUS 11,857,675
TitleMethod for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections